[go: up one dir, main page]

ZA200704489B - Gram positive recombinant protein producing bacteria - Google Patents

Gram positive recombinant protein producing bacteria

Info

Publication number
ZA200704489B
ZA200704489B ZA200704489A ZA200704489A ZA200704489B ZA 200704489 B ZA200704489 B ZA 200704489B ZA 200704489 A ZA200704489 A ZA 200704489A ZA 200704489 A ZA200704489 A ZA 200704489A ZA 200704489 B ZA200704489 B ZA 200704489B
Authority
ZA
South Africa
Prior art keywords
fbfp
useful
recombinant protein
gram positive
producing bacteria
Prior art date
Application number
ZA200704489A
Other languages
English (en)
Inventor
Berger Eldie
Louw Maureen Elizabeth
Crampton Michael Craig
Original Assignee
Csir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csir filed Critical Csir
Priority to ZA200704489A priority Critical patent/ZA200704489B/xx
Publication of ZA200704489B publication Critical patent/ZA200704489B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2101/00—Nature of the contaminant
    • C02F2101/10—Inorganic compounds
    • C02F2101/20—Heavy metals or heavy metal compounds
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F3/00—Biological treatment of water, waste water, or sewage
    • C02F3/34—Biological treatment of water, waste water, or sewage characterised by the microorganisms used
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Water Treatment By Sorption (AREA)
ZA200704489A 2004-12-02 2007-05-30 Gram positive recombinant protein producing bacteria ZA200704489B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA200704489A ZA200704489B (en) 2004-12-02 2007-05-30 Gram positive recombinant protein producing bacteria

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200409786 2004-12-02
ZA200704489A ZA200704489B (en) 2004-12-02 2007-05-30 Gram positive recombinant protein producing bacteria

Publications (1)

Publication Number Publication Date
ZA200704489B true ZA200704489B (en) 2008-11-26

Family

ID=36586075

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200704489A ZA200704489B (en) 2004-12-02 2007-05-30 Gram positive recombinant protein producing bacteria

Country Status (12)

Country Link
US (1) US7888064B2 (xx)
EP (1) EP1836221B1 (xx)
JP (1) JP2008521431A (xx)
CN (1) CN101128480A (xx)
AT (1) ATE518881T1 (xx)
AU (1) AU2005323811B2 (xx)
BR (1) BRPI0515748A (xx)
CA (1) CA2588871A1 (xx)
NO (1) NO20073288L (xx)
RU (1) RU2007124731A (xx)
WO (1) WO2006072845A2 (xx)
ZA (1) ZA200704489B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008523818A (ja) * 2004-12-16 2008-07-10 ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ 腫瘍免疫療法におけるフラジェリンの使用
WO2009087508A1 (en) 2008-01-08 2009-07-16 Csir Production of heterologous proteins or peptides
WO2010141312A2 (en) * 2009-06-01 2010-12-09 Wake Forest University Health Sciences Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
FR2949459B1 (fr) * 2009-08-28 2014-10-17 Otv Sa Agent de prevention et/ou de lutte contre le moussage biologique
US8765425B2 (en) 2011-03-23 2014-07-01 Butamax Advanced Biofuels Llc In situ expression of lipase for enzymatic production of alcohol esters during fermentation
US8759044B2 (en) 2011-03-23 2014-06-24 Butamax Advanced Biofuels Llc In situ expression of lipase for enzymatic production of alcohol esters during fermentation
JP5943463B2 (ja) * 2012-03-05 2016-07-05 国立大学法人神戸大学 レアメタル結合能を有する人工ペプチドおよびその利用
CN103031328B (zh) * 2012-11-22 2015-08-05 江南大学 利用一种融合标签提高外源蛋白质的表达量
JP2015100764A (ja) * 2013-11-26 2015-06-04 株式会社東芝 汚泥処理装置、及び汚泥処理方法
JP6377553B2 (ja) * 2015-03-13 2018-08-22 株式会社東芝 汚泥処理システム
JP6377552B2 (ja) * 2015-03-13 2018-08-22 株式会社東芝 汚泥処理システム
JP6591224B2 (ja) * 2015-07-23 2019-10-16 株式会社東芝 処理装置及び処理方法
US10849938B2 (en) 2017-09-13 2020-12-01 ZBiotics Company Gene expression system for probiotic microorganisms
CN108060171B (zh) * 2017-12-27 2020-11-06 中南大学 一种表面展示金属结合蛋白基因及其在回收铂钯金属中的应用
JP7558167B2 (ja) 2018-12-03 2024-09-30 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム オリゴベンズアミド類似体およびがん処置におけるそれらの使用
CN111249444B (zh) * 2020-03-10 2023-04-07 西北大学 一种用于抑制白色念珠菌的制剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002385A1 (en) * 1985-10-11 1987-04-23 Genetics Institute, Inc. Method for producing heterologous proteins
DE3787820T2 (de) * 1986-03-11 1994-04-28 Shionogi & Co Für Flagellin kodierende DNS und dieses enthaltender Vektor.
AU637049B2 (en) 1988-05-05 1993-05-20 American Cyanamid Company Recombinant flagellin vaccines
ES2176082B1 (es) * 2000-05-31 2004-01-01 Consejo Superior Investigacion Bacterias con la capacidad de unir metales pesados y su empleo en la detoxificacion de medios contaminados con metales pesados.
WO2003011487A1 (en) * 2001-07-27 2003-02-13 Global Biosciences, Inc. Remediation of metal contaminants with hydrocarbon-utilizing bacteria
WO2003078451A2 (en) * 2002-03-13 2003-09-25 New Century Pharmaceuticals, Inc. Method of isolating binding peptides from a combinatorial phage display library and peptides produced thereby
DE10220094B4 (de) 2002-05-04 2004-02-26 Ontoprise Gmbh Datenverarbeitungssystem
WO2003094849A2 (en) * 2002-05-10 2003-11-20 New Century Pharmaceuticals, Inc. Ferritin fusion proteins for use in vaccines and other applications
JP2006181393A (ja) * 2003-03-10 2006-07-13 Ip Bio Corp ノンスラッジ高速排水処理システム
DK1661910T3 (da) * 2003-07-30 2013-12-16 Japan Science & Tech Agency Peptider, der er i stand til at binde til titan, sølv og silicium

Also Published As

Publication number Publication date
CA2588871A1 (en) 2006-07-13
NO20073288L (no) 2007-08-16
AU2005323811B2 (en) 2012-07-05
ATE518881T1 (de) 2011-08-15
EP1836221A2 (en) 2007-09-26
EP1836221B1 (en) 2011-08-03
US7888064B2 (en) 2011-02-15
BRPI0515748A (pt) 2008-08-05
AU2005323811A1 (en) 2006-07-13
JP2008521431A (ja) 2008-06-26
US20080003237A1 (en) 2008-01-03
WO2006072845A2 (en) 2006-07-13
RU2007124731A (ru) 2009-01-10
CN101128480A (zh) 2008-02-20
WO2006072845A3 (en) 2007-03-01

Similar Documents

Publication Publication Date Title
ZA200704489B (en) Gram positive recombinant protein producing bacteria
WO2005071088A3 (en) Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof
ZA202304237B (en) Dna modifying enzymes and active fragments and variants thereof and methods of use
GB0614614D0 (en) Gene expression technique
WO2004099370A3 (en) NOVEL BACILLUS mHKcel CELLULASE
KR20170085129A (ko) 펩티드 생산용 융합 파트너
WO2004096992A3 (en) Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
WO2005086794A3 (en) Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
WO2003025117A3 (en) Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor
AU6020998A (en) Methods for production of proteins
WO2006137836A3 (en) Bacterial vector systems
WO2001094383A3 (en) Mutated furin polypeptides having improved characteristics
WO2005081959A3 (en) Lactobacillus acidophilus nucleic acid sequences encoding protease homologues and uses therefor
EP1321517A3 (en) Gluconobacter oxydans 2-ketoreductase enzyme and applications thereof
WO2002048187A3 (de) Sekretionssignalpeptide, deren dna-sequenzen, damit herstellbare expressionsvektoren für eukaryotische zellen und deren verwendung zur biotechnologischen herstellung von protein
WO2005017162A3 (en) Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides
WO2001032872A3 (en) Twik potassium channel molecules and uses therefor
WO1997031612A3 (en) Mammalian endonuclease iii, and diagnostic and therapeutic uses thereof
AU8493198A (en) Increasing production of proteins in gram-positive microorganisms
WO2003070963A3 (en) Improved protein expression in bacillus subtilis
GB9930480D0 (en) Production of heterologous proteins
Kim et al. Secretory overproduction of the aminopeptidase from Bacillus licheniformis by a novel hybrid promoter in Bacillus subtilis
HK1098673A1 (zh) 重组编码融合蛋白的核酸分子，该融合蛋白包括抗原和细菌分泌的信号多肽，表达框架，和细菌，及其使用方法
EP0806480A3 (en) Frenolicin gene cluster
EP1561810A3 (en) Mutant microorganism and method for producing peptide using the same